由Future Drugs出版。國(guó)際標(biāo)準(zhǔn)編號(hào)：1476-0584。過去十年的技術(shù)進(jìn)步改變了疫苗領(lǐng)域。我們現(xiàn)在開始設(shè)想疫苗的未來(lái)影響，從醫(yī)療保健和經(jīng)濟(jì)角度來(lái)看。預(yù)防性疫苗繼續(xù)提供生活質(zhì)量的革命，特別是在發(fā)展中國(guó)家的人口中。將該領(lǐng)域擴(kuò)展到治療性疫苗領(lǐng)域，將從根本上改變醫(yī)療保健和研發(fā)界對(duì)疫苗的更廣泛認(rèn)識(shí)。在治療艾滋病、癌癥和其他主要疾病的治療疫苗的前景方面，預(yù)計(jì)將取得迅速進(jìn)展。在提供經(jīng)濟(jì)有效、安全的疫苗方面仍然存在許多挑戰(zhàn)。對(duì)疫苗的專家審查提供了關(guān)于新疫苗和疫苗技術(shù)的開發(fā)和應(yīng)用的結(jié)構(gòu)化、知情的評(píng)論，所有文章都要經(jīng)過嚴(yán)格的同行審查。

Published by Future-Drugs. ISSN: 1476-0584.The vaccine field has been transformed by the technological advances of the past decade. We are now beginning to visualize the future impact of vaccines, in terms of both healthcare and economics. Prophylactic vaccines continue to offer a revolution in quality of life, particularly among the populations of developing countries. Expansion of the field into the area of therapeutic vaccines is set to change radically the wider perception of vaccines in the healthcare and R&D communities. Rapid advances are anticipated with the prospect of therapeutic vaccines for the treatment of AIDS, cancer and other major diseases. There remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines provides structured, informed commentary on the development and application of new vaccines and vaccine technologies, with all articles subject to rigorous peer-review.